Background. Diabetic foot ulcers are one disabling complication of diabetes mellitus.
Pirfenidone (PFD) is a potent modulator of extracellular matrix. Modified diallyl disulfide …

Only 30 percent of chronic diabetic foot ulcers heal after 20 weeks of standard treatment.
Pirfenidone is a drug with biological, anti‐inflammatory, and antifibrotic effects. The aim of …

We examined the role of vascular function and inflammation in the development and failure
to heal diabetic foot ulcers (DFUs). We followed 104 diabetic patients for a period of …

Background: Diabetes foot ulcers (DFU) are among the most common complications in
diabetic patients, leading to amputation and psychological distress. This mini-review covers …

Objective: To assess the safety/tolerability and perform a preliminary efficacy evaluation of a
multiple-dosing regimen of recombinant human vascular endothelial growth factor …

Abstract Treatment for diabetic foot ulcer (DFU) remains as one of the biggest clinical
concerns in diabetic disease. DFU often causes a prolonged treatment and eventually leads …

Diabetic foot ulcers (DFUs) are one the common complications of diabetes mellitus. Many
trials were performed to evaluate the effect of recombinant human epidermal growth factor …

Diabetic foot ulcer (DFU) is a major complication of diabetes and is associated with a high
risk of lower limb amputation and mortality. During their lifetime, 19%–34% of patients with …

Introduction Diabetic foot ulcers (DFU) are one of the leading long-term complications
experienced by patients with diabetes. Dipeptidyl Peptidase 4 inhibitors (DPP4is) are a …

Diabetic foot ulcers (DFUs) have become one of the important causes of mortality and
morbidity in patients with diabetes, and they are also a common cause of hospitalization …